Oncology
Lorlatinib
ALK-positive metastatic non-small cell lung cancer treatment
View Details
Our Products
We offer a comprehensive range of innovative pharmaceutical products across oncology, metabolic diseases, and infectious diseases.
Metabolic
Orforglipron
Oral GLP-1 receptor agonist for type 2 diabetes and weight management
View Details
Metabolic
Tirzepatide
Dual GIP/GLP-1 receptor agonist for diabetes and chronic weight management
View Details
Oncology
Capmatinib
MET inhibitor for metastatic NSCLC with MET exon 14 skipping mutations
View Details
Infectious Disease
Lenacapavir
HIV capsid inhibitor for multi-drug resistant HIV-1 and PrEP
View Details
Metabolic
Semaglutide
GLP-1 receptor agonist for type 2 diabetes, weight management, and cardiovascular risk reduction
View Details